Clin Res Hepatol Gastroenterol 46(6):101922 Niu S, Chen S, Chen X, Ren Q, Yue L, Pan X, Zhao H, Li Z, Chen X (2022) Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
Medications like Ozempic and Mounjaro (approved for type 2 diabetes) and Wegovy and Zepbound (approved for weight management) amplify these effects
doi: 10.1111/dom.13137 34 TrujilloJMNufferWSmithBA
GLP-1Ra at doses intended for T2D management Studies have examined the risk of fracture in both obese and non-obese individuals taking GLP-1Ra at doses intended for T2D (such as liraglutide 1.2 mg daily versus 3.0 mg daily for obesity) [75,76,77]
The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype
& Engel, S